Ambey Laboratories
Ambey Laboratories (DHANSA) share price was ₹24.20 at the 28 Oct 2026 close; market capitalisation ₹65.11 Cr; P/E (TTM) 17.29; sector Chemicals. The share price fell 39.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Sep 2025 quarter, revenue was ₹68 Cr, against ₹68 Cr a year earlier and net profit was ₹3 Cr, against ₹3 Cr a year earlier (compared with Sep 2024). Promoters held 65.05% of Ambey Laboratories in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 36/100 (Poor) as of 28 Oct 2026.
Key Fundamentals
SMEFertilizers & AgrochemicalsChemicalsPrice-based figures as of 28 Oct 2026, 12:05 IST · TTM
Peer Comparison
Commodities › Chemicals › Pesticides & Agrochemicals
| ₹544.05 | 22.72 | 45,927 Cr | 1.32 | 1.16% | 5.38% | 10.85% | 53,683 Cr | 2,323 Cr | |
| ₹2,106.90 | 27.43 | 31,965 Cr | 2.85 | 0.72% | 11.76% | 14.68% | 6,914 Cr | 1,164 Cr | |
| ₹334.25 | 28.77 | 16,684 Cr | 4.51 | 0.38% | 16.00% | 20.98% | 3,409 Cr | 581 Cr | |
| ₹3,294.40 | 20.22 | 14,806 Cr | 4.99 | 4.59% | 23.24% | 27.93% | 5,761 Cr | 733 Cr | |
| ₹693.35 | 9.99 | 6,255 Cr | 1.99 | 2.31% | 21.71% | 25.26% | 5,464 Cr | 626 Cr | |
| ₹884.00 | 14.84 | 3,941 Cr | 2.34 | 0.23% | 21.17% | 27.37% | 2,071 Cr | 268 Cr | |
| ₹188.17 | 17.09 | 3,659 Cr | 1.67 | 1.58% | 9.68% | 12.75% | 2,631 Cr | 214 Cr | |
Ambey Laboratories (this company) | ₹24.20 | 17.29 | 65 Cr | 0.81 | 0.00% | 5.59% | 8.48% | 105 Cr | 4 Cr |
| ₹24.20 | — | — | — | — | — | — | — | — | |
| Median 9 companies | ₹544.05 | 18.76 | 10,531 Cr | 2.17 | 0.94% | 13.88% | 17.83% | 4,437 Cr | 604 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 98/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.68 times its book value
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 60.5 to 112 days.
- Working capital days have increased from 64.4 days to 126 days
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
Operating margin 9% · Sep 2025
Quarterly Results
| Particulars | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|
| Sales | 60 | 68 | 64 | 68 |
| Expenses | 56 | 62 | 60 | 62 |
| Operating Profit | 4 | 6 | 4 | 6 |
| OPM % | 7% | 9% | 6% | 9% |
| Other Income | 1 | 1 | 1 | 0 |
| Interest | 1 | 2 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 2 |
| PBT | 3 | 4 | 2 | 3 |
| Tax % | 33% | 18% | 25% | 13% |
| Net Profit | 2 | 3 | 2 | 3 |
| EPS (₹) | 0.94 | 1.19 | 0.73 | 1.05 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 82 | 85 | 105 | 120 | 131 | 132 |
| Expenses | 72 | 74 | 97 | 111 | 122 | 122 |
| Operating Profit | 10 | 10 | 8 | 9 | 10 | 10 |
| OPM % | 12% | 12% | 7% | 8% | 7% | 7% |
| Other Income | 1 | 1 | 3 | 1 | 2 | 1 |
| Interest | 4 | 3 | 2 | 2 | 3 | 2 |
| Depreciation | 3 | 3 | 3 | 2 | 3 | 4 |
| PBT | 3 | 5 | 6 | 6 | 6 | 5 |
| Tax % | -235% | 26% | 5% | -40% | 21% | — |
| Net Profit | 10 | 4 | 5 | 8 | 5 | 4 |
| EPS (₹) | 211 | 20.11 | 29.52 | 4.13 | 1.92 | 1.78 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 5 | 18 | 18 | 19 | 25 | 25 |
| Reserves | -13 | 1 | 1 | 13 | 51 | 67 |
| Borrowings | 33 | 18 | 14 | 30 | 41 | 40 |
| Other Liabilities | 20 | 19 | 21 | 18 | 10 | 9 |
| Total Liabilities | 45 | 56 | 54 | 79 | 127 | 140 |
| Fixed Assets | 16 | 25 | 25 | 24 | 23 | 22 |
| CWIP | 1 | 0 | 0 | 4 | 16 | 17 |
| Investments | 0 | 0 | 1 | 1 | 0 | 0 |
| Other Assets | 28 | 31 | 28 | 51 | 88 | 101 |
| Total Assets | 45 | 56 | 54 | 79 | 127 | 140 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | 3 | 6 | 10 | -13 | -34 |
| Investing | -1 | -1 | -4 | -5 | -14 |
| Financing | -1 | -5 | -6 | 18 | 48 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 2 | 5 | 7 | -18 | -48 |
| CFO/OP | 23 | 47 | 120 | -131 | -347 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 31 | 37 | 12 | 57 | 112 |
| Inventory Days | — | — | 78 | 75 | 99 |
| Days Payable | — | — | 74 | 54 | 22 |
| Cash Conversion Cycle | 31 | 37 | 17 | 78 | 189 |
| Working Capital Days | -10 | 11 | 18 | 49 | 126 |
| ROCE % | — | 25% | 22% | 18% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ambey Laboratories insights
29 extracted metrics + investor summaries across FY21–FY26.
Documents
Frequently Asked Questions about Ambey Laboratories
What does Ambey Laboratories Ltd do?
Where is Ambey Laboratories Ltd (DHANSA) listed?
Which sector does Ambey Laboratories Ltd belong to?
What is the market capitalisation of Ambey Laboratories Ltd?
What is the PE ratio of Ambey Laboratories Ltd?
What is the 52-week high and low of Ambey Laboratories Ltd?
What is the Return on Equity (ROE) of Ambey Laboratories Ltd?
Company Information
Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AMBEY.md for Ambey Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.